2024-11-20 00:31:06
Alphamab Received U.S. FDA IND Clearance to Initiate A Phase II Pivotal Clinical Trial of KN046 (KN046-205,ENREACH-Thymic) in the U.S.
Corporate/ 2023-07-23
Alphamab Received U.S. FDA IND Clearance...

SUZHOU,China,March 9,2021-- Alphamab Oncology (stock code: 9966.HK) announced that U.S. Food and Drug Administration (FDA) has cleared the C...

Insilico's Chemistry42 AI system integrated into UCB's drug discovery programs
Corporate/ 2023-07-23
Insilico's Chemistry42 AI system in...

HONG KONG,March 9,2021--Insilico Medicine,an AI drug discovery company,announced that UCB will integrate Insilico\'s Chemistry42™ into UCB\...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release